Cantor Fitzgerald’s OnKure Therapeutics OKUR Stock Holding History
Bought
Maintained
Sold
Other funds holding OKUR
ACA
Cantor Fitzgerald's OKUR Position: Q3 2026 in Review
Cantor Fitzgerald held its OnKure Therapeutics (OKUR) position steady in Q3 2026 at 100,014 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #563.
Cantor Fitzgerald first reported a position in OKUR in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.6M in Q2 2025. 81 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.
- Cantor Fitzgerald held 100,014 shares of OnKure Therapeutics worth $273K as of Q3 2026.
- Cantor Fitzgerald left its OnKure Therapeutics share count unchanged in Q3 2026.
- OnKure Therapeutics made up ﹤0.01% of Cantor Fitzgerald's portfolio in Q3 2026, its #563 holding.
- Cantor Fitzgerald first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Cantor Fitzgerald's OnKure Therapeutics position peaked at $1.6M in Q2 2025.
- 81 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.
Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.